Enliven Therapeutics, Inc. (ELVN)
25.61
-1.42
(-5.25%)
USD |
NASDAQ |
Jan 23, 13:56
Enliven Therapeutics Total Liabilities (Quarterly): 14.75M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Coherus Oncology, Inc. | 428.74M |
| Allogene Therapeutics, Inc. | 124.44M |
| Pyxis Oncology, Inc. | 36.82M |
| CEL-SCI Corp. | 12.20M |
| AIM ImmunoTech, Inc. | 11.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 490.88M |
| Shareholders Equity (Quarterly) | 476.12M |
| Debt to Equity Ratio | 0.0008 |
| Current Ratio | 32.95 |
| Net Debt Paydown Yield | -0.00% |